ClinicalTrials.gg
CompletedNCT05465577CC LinksUpdated Jul 22, 2024

Coverage and Cost-of-Care (CC) Links- Financial Navigation Program

An interventional study of CC Links in Financial Stress, Hematologic Cancer and Survivorship, sponsored by Jean Edward. Completed at 1 site in United States. Open to participants aged 18 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-22.

Sponsored by Jean Edward · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Apr 2021, registered Jul 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
94
Allocation
Non-randomized
Ages
18 Years to 100 Years
Sex
All
01

Study summary

This trial is a mixed-methods, non-randomized design guided by the Consolidated Framework for Implementation Research (CFIR) to develop, implement, and evaluate Coverage and Cost-of-Care Links (CC Links) -a novel financial navigation intervention for hematologic cancer survivors and their caregivers.

Read the detailed description

The CC Links intervention included an oncology financial navigator who worked in the Hematology-Oncology Clinic. The navigator's functions included: screening for financial hardship to identify unmet financial needs (using the Comprehensive Score for Financial Toxicity (COST) and National Comprehensive Cancer Network's Distress Thermometer; initiating cost of care conversations; providing cost of care estimates; ensuring adequate health insurance coverage and assisting with applying for additional coverage; assisting with internal financial assistance program applications; connecting survivors/caregivers with disease specific resources and other external assistance programs; coordinating discharge planning; referring survivors to social workers and other staff/resources as needed; and, coordinating financial assistance services as survivors/caregivers transition between outpatient and inpatient settings.

02

Conditions studied

  • Financial Stress
  • Hematologic Cancer
  • Survivorship

Keywords

  • financial navigation
  • quality of life
  • hardship
  • caregivers
  • financial toxicity
03

In context

Financial Stress

97 studies on the registry are indexed under Financial Stress; 33 are open to participants now.

This study's enrollment of 94 is below the median of 124 across 57 interventional studies indexed under Financial Stress.

Browse Financial Stress studies →

Lead sponsor

Jean Edward is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • hematological cancer patients from the Division of Hematology and Bone Marrow Transplantation at the University of Kentucky
  • caregivers of cancer patients
  • positive screening for financial hardship

Exclusion criteria

Exclusion Criteria:

- unable to provide consent

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
94 participants (actual)

Study arms

  • Experimental
    Financial Navigation- Patients Only

    Patients only participated in financial navigation program.

    Other: CC Links

  • Experimental
    Financial Navigation- Patient and Caregiver

    Patients and their caregivers participated as a dyad in financial navigation program.

    Other: CC Links

Interventions

  • OtherCC Links

    The CC Links intervention is built on a platform of interdisciplinary team-based science, which ensured that the financial navigator worked closely with other members of the healthcare team including oncologists, nurses, transplant coordinators, social workers, and case managers, to help enhance financial hardship screening and connect survivors and caregivers with financial assistance services.

06

What researchers measure

Primary outcomes

  1. Change in coping behaviors

    "Coping behaviors" was measured using a series of 9 yes/no items that first assess whether any recommended cancer care was skipped for any reason (yes/no), and then whether the reason for not receiving the care that they or their doctor believed necessary was due to any of 8 listed reasons (yes/no for each). Typical reasons included 'Couldn't afford care,' 'Insurance company wouldn't approve or pay for care,' and 'Had problems getting to the doctor's office.' The sum of the number of yes responses is the total score, with higher scores indicating greater coping behaviors in response to financial hardship. The items in this scale are from the Medical Expenditure Panel Survey - Experiences with Cancer Survivorship Survey (MEPS-ECSS).

    Time frame: Approximately 8 months (baseline and following resolution of financial needs)

  2. Change in material conditions

    "Material conditions" was measured using 8 items (6 from the Medical Expenditure Panel Survey: Experiences with Cancer Survivorship Supplement (MEPS-ECSS) and 2 from demographic survey) that measure the financial condition of the participant with cancer and their family. Six of the items are yes/no and these include questions on borrowing money or go into debt, filing for bankruptcy, and concerns about having to pay large medical bills because of the cost of cancer treatment. The remaining two items are ordinal and measure the amount of debt related to cancer costs (options range from $0 to $100,00+), and the how they perceive their household's income currently (choices range from 'living comfortably on present income' to 'finding it very difficult on present income'). The latter two items are rescaled to 0-1 variables, so they have the same ranges as the yes/no items and are summed to create the total score. Higher scores indicate greater financial hardship.

    Time frame: Approximately 8 months (baseline and following resolution of financial needs)

  3. Change in psychological response (financial toxicity)

    Psychological response (i.e. financial toxicity) was measured using the 11-item Comprehensive Score for Financial Toxicity (COST) that measures emotional aspects of financial hardship (financial toxicity) among cancer patients. Each item is scored on a 5-point ordinal scale ranging from 0='Not at all' to 4='Very much.' Sample items include 'My out-of-pocket expense are more than I thought they would be' and 'I am frustrated that I cannot work or contribute as much as I usually do.' Lower values indicate greater financial toxicity.

    Time frame: Approximately 8 months (baseline and following resolution of financial needs)

  4. Change in health-related quality of life

    Health-related QOL was measured using four Patient-Reported Outcomes Measurement Information System (PROMIS) scales.xx Each of these were scored and standardized by submitting the raw values to the HealthMeasures scoring service. standardized values of the total scores were used throughout the analysis for this study. The four scales include the PROMIS physical health and emotional health subscales (from the 10-item PROMIS Scale v1.2 - Global Health),xx the 4-item PROMIS- Anxiety Short Form, and the 6-item PROMIS-Depression Short Form. The physical (physical health, function, pain, and fatigue items) and emotional health (QOL, mental health, social activities, and emotional problem items) subscales are each based on 4 items, with higher scores indicating a more positive health self-assessment. For the anxiety and depression scales, higher scores indicate a greater manifestation of symptoms.

    Time frame: Approximately 8 months (baseline and following resolution of financial needs)

  5. Change in distress.

    Distress was measured using the National Comprehensive Cancer Network's (NCCN) Distress Thermometer and its accompanying 40-item problem list. A cutoff score of 4 indicated clinically elevated distress levels

    Time frame: Approximately 8 months (baseline and following resolution of financial needs)

Secondary outcomes

  1. Financial Savings

    Amount of money saved per patient including grants and financial assistance received, total charges, financial assistance adjustments, insurance payments, and insurance charges.

    Time frame: Approximately at 8 months (following resolution of financial needs)

07

Study locations

1 site
  • University of Kentucky
    Lexington, Kentucky 40536, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05465577
Lead sponsor
Jean Edward
Responsible party
Jean Edward (Associate Professor, University of Kentucky) — Sponsor-investigator
First posted
Jul 20, 2022
Start date
Apr 1, 2021
Primary completion
Feb 1, 2022
Completion
Feb 1, 2022
Last update
Jul 22, 2024

Study contacts

Jean S Edward, PhD, RN
principal investigator · University of Kentucky

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion